2021 annual financial data
Immix Biopharma 2021 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -1,352,014 USD and net income was -24,383,879 USD.
Operating cash flow was -1,589,307 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,352,014 USD
- Net income
- -24,383,879 USD
- Operating cash flow
- -1,589,307 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immix Biopharma financial years